Search Page
Save citations to file
Email citations
Email address has not been verified. Go to
My NCBI account settings
to confirm your email and then refresh this page.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2025 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
Lancet Neurol. 2023 May;22(5):395-406. doi: 10.1016/S1474-4422(23)00080-7.
Lancet Neurol. 2023.
PMID: 37059508
Clinical Trial.
Efficacy of zilucoplan in patients with generalised myasthenia gravis who have not previously received immunoglobulin or plasma exchange: A subgroup analysis from the Phase 3 RAISE study.
Utsugisawa K, Masuda M, Boroojerdi B, Grimson F, Howard JF Jr; RAISE Study Team.
Utsugisawa K, et al.
J Neurol Sci. 2025 Jul 15;474:123550. doi: 10.1016/j.jns.2025.123550. Epub 2025 May 16.
J Neurol Sci. 2025.
PMID: 40450840
Free article.
Clinical Trial.
Item in Clipboard
Score fluctuation might be associated with a higher placebo rate in the RAISE trial - Authors' reply.
Howard JF Jr, Boroojerdi B, de la Borderie G, Leite MI, Utsugisawa K; RAISE Study Team.
Howard JF Jr, et al.
Lancet Neurol. 2023 Nov;22(11):982-983. doi: 10.1016/S1474-4422(23)00365-4.
Lancet Neurol. 2023.
PMID: 37863600
No abstract available.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.